Bristol Myers Squibb EBIT 2010-2025 | BMY

Bristol Myers Squibb annual and quarterly EBIT history from 2010 to 2025. EBIT can be defined as earnings before interest and taxes.
  • Bristol Myers Squibb EBIT for the quarter ending March 31, 2025 was $2.970B, a 125.79% decline year-over-year.
  • Bristol Myers Squibb EBIT for the twelve months ending March 31, 2025 was $6.107B, a 204.46% decline year-over-year.
  • Bristol Myers Squibb 2024 annual EBIT was $-8.379B, a 199.28% decline from 2023.
  • Bristol Myers Squibb 2023 annual EBIT was $8.44B, a 9.43% increase from 2022.
  • Bristol Myers Squibb 2022 annual EBIT was $7.713B, a 4.75% decline from 2021.
Bristol Myers Squibb Annual EBIT
(Millions of US $)
2024 $-8,379
2023 $8,440
2022 $7,713
2021 $8,098
2020 $-6,871
2019 $4,975
2018 $5,968
2017 $5,131
2016 $5,915
2015 $2,077
2014 $2,381
2013 $2,891
2012 $4,170
2011 $6,981
2010 $6,071
2009 $5,320
Bristol Myers Squibb Quarterly EBIT
(Millions of US $)
2025-03-31 $2,970
2024-12-31 $175
2024-09-30 $1,676
2024-06-30 $1,286
2024-03-31 $-11,516
2023-12-31 $1,674
2023-09-30 $2,137
2023-06-30 $1,859
2023-03-31 $2,770
2022-12-31 $1,859
2022-09-30 $2,209
2022-06-30 $1,958
2022-03-31 $1,687
2021-12-31 $1,858
2021-09-30 $2,157
2021-06-30 $1,553
2021-03-31 $2,530
2020-12-31 $-10,451
2020-09-30 $2,257
2020-06-30 $1,627
2020-03-31 $-304
2019-12-31 $-129
2019-09-30 $1,349
2019-06-30 $1,776
2019-03-31 $1,979
2018-12-31 $1,505
2018-09-30 $2,167
2018-06-30 $517
2018-03-31 $1,779
2017-12-31 $698
2017-09-30 $1,183
2017-06-30 $1,295
2017-03-31 $1,955
2016-12-31 $1,086
2016-09-30 $1,559
2016-06-30 $1,615
2016-03-31 $1,655
2015-12-31 $-410
2015-09-30 $987
2015-06-30 $52
2015-03-31 $1,448
2014-12-31 $-60
2014-09-30 $1,008
2014-06-30 $448
2014-03-31 $985
2013-12-31 $869
2013-09-30 $818
2013-06-30 $530
2013-03-31 $674
2012-12-31 $513
2012-09-30 $571
2012-06-30 $1,059
2012-03-31 $2,027
2011-12-31 $1,717
2011-09-30 $1,767
2011-06-30 $1,768
2011-03-31 $1,729
2010-12-31 $1,593
2010-09-30 $1,581
2010-06-30 $1,531
2010-03-31 $1,366
2009-12-31 $1,252
2009-09-30 $1,477
2009-06-30 $1,419
2009-03-31 $1,172
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $102.914B $48.300B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) GB $224.654B 16.77
Amgen (AMGN) US $151.198B 13.55
Gilead Sciences (GILD) US $129.098B 13.40
Vertex Pharmaceuticals (VRTX) US $128.836B 0.00
GSK (GSK) GB $80.610B 9.58
CSL (CSLLY) AU $80.379B 0.00
Regeneron Pharmaceuticals (REGN) US $66.208B 15.87
Argenex SE (ARGX) NL $39.669B 272.97
Alnylam Pharmaceuticals (ALNY) US $33.821B 0.00
BeiGene (ONC) KY $25.298B 0.00
BioNTech SE (BNTX) DE $25.183B 0.00
Biogen (BIIB) US $18.101B 7.81
Genmab (GNMSF) DK $14.542B 14.98
Genmab (GMAB) DK $13.773B 17.32
Insmed (INSM) US $13.146B 0.00
Illumina (ILMN) US $12.326B 31.79
Incyte (INCY) US $12.104B 91.96
BioMarin Pharmaceutical (BMRN) US $11.836B 19.32
Exelixis (EXEL) US $10.913B 22.63
Swedish Orphan Biovitrum (BIOVF) SE $10.858B 27.73
Moderna (MRNA) US $10.678B 0.00
Ascendis Pharma (ASND) DK $10.491B 0.00
Exact Sciences (EXAS) US $9.724B 0.00
QIAGEN (QGEN) NL $9.587B 19.30
Roivant Sciences (ROIV) GB $8.192B 0.00
Bio-Techne Corp (TECH) US $7.982B 30.60
Repligen (RGEN) US $7.946B 89.00
Revolution Medicines (RVMD) US $7.585B 0.00
Halozyme Therapeutics (HALO) US $7.559B 15.61
Jazz Pharmaceuticals (JAZZ) IE $7.399B 6.59
TG Therapeutics (TGTX) US $6.897B 310.29
Blueprint Medicines (BPMC) US $6.758B 0.00
Bio-Rad Laboratories (BIO.B) US $6.566B 22.20
Telix Pharmaceuticals (TLX) AU $6.318B 0.00
Sarepta Therapeutics (SRPT) US $6.240B 29.00
Verona Pharma American Depositary Share (VRNA) GB $6.181B 0.00
Legend Biotech (LEGN) US $6.092B 0.00
Guardant Health (GH) US $5.804B 0.00
ADMA Biologics Inc (ADMA) US $5.589B 47.04
Nuvalent (NUVL) US $5.546B 0.00
Axsome Therapeutics (AXSM) US $5.523B 0.00
Zealand Pharma (ZLDPF) DK $5.337B 0.00
Alkermes (ALKS) IE $5.241B 14.06
Krystal Biotech (KRYS) US $4.802B 50.05
Vaxcyte (PCVX) US $4.565B 0.00
Cytokinetics (CYTK) US $4.452B 0.00
Rhythm Pharmaceuticals (RYTM) US $4.071B 0.00
PTC Therapeutics (PTCT) US $3.958B 0.00
Avidity Biosciences (RNA) US $3.881B 0.00
Ultragenyx Pharmaceutical (RARE) US $3.690B 0.00
Arcellx (ACLX) US $3.610B 0.00
Akero Therapeutics (AKRO) US $3.575B 0.00
SpringWorks Therapeutics (SWTX) US $3.467B 0.00
Zai Lab (ZLAB) CN $3.440B 0.00
CRISPR Therapeutics AG (CRSP) CH $3.303B 0.00
Viking Therapeutics (VKTX) US $3.297B 0.00
Scholar Rock Holding (SRRK) US $3.122B 0.00
Merus (MRUS) NL $3.057B 0.00
Xenon Pharmaceuticals (XENE) CA $2.932B 0.00
Protagonist Therapeutics (PTGX) US $2.820B 10.84
MoonLake Immunotherapeutics (MLTX) CH $2.709B 0.00
Metsera (MTSR) US $2.695B 0.00
Immunovant (IMVT) US $2.684B 0.00
HUTCHMED (China) (HCM) HK $2.615B 0.00
Apellis Pharmaceuticals (APLS) US $2.556B 0.00
ACADIA Pharmaceuticals (ACAD) US $2.495B 22.25
Alvotech (ALVO) LU $2.478B 0.00
Denali Therapeutics (DNLI) US $2.388B 0.00
Twist Bioscience (TWST) US $2.341B 0.00
Biohaven (BHVN) US $2.332B 0.00
Kymera Therapeutics (KYMR) US $2.297B 0.00
ImmunityBio (IBRX) US $2.242B 0.00
Ascentage Pharma Group - (AAPG) CN $2.219B 0.00
CG Oncology (CGON) US $2.214B 0.00
Mirum Pharmaceuticals (MIRM) US $2.161B 0.00
Ligand Pharmaceuticals (LGND) US $2.109B 0.00
Certara (CERT) US $2.098B 44.79
Amicus Therapeutics (FOLD) US $2.054B 222.33
Beam Therapeutics (BEAM) US $2.035B 0.00
NovoCure (NVCR) JE $2.023B 0.00
Kiniksa Pharmaceuticals (KNSA) GB $2.009B 0.00
Belite Bio (BLTE) US $1.995B 0.00
Tarsus Pharmaceuticals (TARS) US $1.990B 0.00
Arrowhead Pharmaceuticals (ARWR) US $1.980B 0.00
Vericel (VCEL) US $1.953B 216.39
Janux Therapeutics (JANX) US $1.945B 0.00
Bavarian Nordic (BVNRY) DK $1.897B 13.37
Travere Therapeutics (TVTX) US $1.878B 0.00
IDEAYA Biosciences (IDYA) US $1.833B 0.00
Arcutis Biotherapeutics (ARQT) US $1.817B 0.00
Apogee Therapeutics (APGE) US $1.801B 0.00
Edgewise Therapeutics (EWTX) US $1.772B 0.00
Agios Pharmaceuticals (AGIO) US $1.743B 0.00
Harmony Biosciences Holdings (HRMY) US $1.740B 12.08
Disc Medicine (IRON) US $1.712B 0.00
Vera Therapeutics (VERA) US $1.613B 0.00
ANI Pharmaceuticals (ANIP) US $1.588B 17.97
Structure Therapeutics (GPCR) US $1.553B 0.00
Mesoblast (MESO) AU $1.540B 0.00
Immunocore Holdings (IMCR) GB $1.525B 0.00
MannKind (MNKD) US $1.519B 31.25
Adaptive Biotechnologies (ADPT) US $1.495B 0.00
Dynavax Technologies (DVAX) US $1.387B 62.94
Celldex Therapeutics (CLDX) US $1.372B 0.00
Liquidia Technologies (LQDA) US $1.353B 0.00
89BIO (ETNB) US $1.274B 0.00
GRAIL (GRAL) US $1.263B 0.00
WAVE Life Sciences (WVE) SG $1.248B 0.00
Pacira BioSciences (PCRX) US $1.224B 11.50
Syndax Pharmaceuticals (SNDX) US $1.181B 0.00
Iovance Biotherapeutics (IOVA) US $1.169B 0.00
BGM Group (BGM) CN $1.138B 0.00
Viridian Therapeutics (VRDN) US $1.111B 0.00
Novavax (NVAX) US $1.031B 0.00
Mineralys Therapeutics (MLYS) US $1.000B 0.00
NeoGenomics (NEO) US $0.991B 0.00
Arcus Biosciences (RCUS) US $0.966B 0.00
Pharvaris (PHVS) NL $0.961B 0.00
MiMedx (MDXG) US $0.933B 22.57
Anbio Biotechnology (NNNN) DE $0.925B 0.00
Intellia Therapeutics (NTLA) US $0.916B 0.00
Spyre Therapeutics (SYRE) US $0.911B 0.00
Zymeworks (ZYME) US $0.902B 0.00
Geron (GERN) US $0.879B 0.00
Gyre Therapeutics (GYRE) US $0.868B 115.75
Nurix Therapeutics (NRIX) US $0.859B 0.00
Rocket Pharmaceuticals (RCKT) US $0.855B 0.00
Vir Biotechnology (VIR) US $0.850B 0.00
Nuvation Bio (NUVB) US $0.833B 0.00
Oculis Holding AG (OCS) CH $0.824B 0.00
Praxis Precision Medicines (PRAX) US $0.820B 0.00
LENZ Therapeutics (LENZ) US $0.813B 0.00
UniQure (QURE) NL $0.809B 0.00
Day One Biopharmaceuticals (DAWN) US $0.804B 0.00
Anavex Life Sciences (AVXL) US $0.799B 0.00
CureVac (CVAC) DE $0.799B 4.34
Regencell Bioscience Holdings (RGC) HK $0.797B 0.00
Bicara Therapeutics (BCAX) US $0.791B 0.00
Replimune (REPL) US $0.771B 0.00
Immunome (IMNM) US $0.770B 0.00
ArriVent BioPharma (AVBP) US $0.725B 0.00
AbCellera Biologics (ABCL) CA $0.719B 0.00
Trevi Therapeutics (TRVI) US $0.698B 0.00
Dianthus Therapeutics (DNTH) US $0.697B 0.00
Myriad Genetics (MYGN) US $0.697B 0.00
Arbutus Biopharma (ABUS) US $0.687B 0.00
Cogent Biosciences (COGT) US $0.668B 0.00
Sinovac Biotech (SVA) CN $0.645B 0.00
Bicycle Therapeutics (BCYC) GB $0.644B 0.00
CorMedix Inc (CRMD) US $0.636B 0.00
Zhengye Biotechnology Holding (ZYBT) CN $0.636B 0.00
Immatics (IMTX) DE $0.636B 37.36
Niagen Bioscience (NAGE) US $0.629B 200.00
AnaptysBio (ANAB) US $0.627B 0.00
Basilea Pharmaceutica AG (BPMUF) CH $0.626B 0.00
Pharming Group (PHGUF) NL $0.613B 0.00
Pharming Group (PHAR) NL $0.610B 0.00
Sionna Therapeutics (SION) US $0.599B 0.00
Keros Therapeutics (KROS) US $0.595B 0.00
GH Research (GHRS) IE $0.593B 0.00
MeiraGTx Holdings (MGTX) US $0.580B 0.00
Tyra Biosciences (TYRA) US $0.577B 0.00
Fortrea Holdings (FTRE) US $0.567B 18.41
Arvinas (ARVN) US $0.563B 0.00
Kura Oncology (KURA) US $0.560B 0.00
Castle Biosciences (CSTL) US $0.558B 31.21
Urogen Pharma (URGN) US $0.531B 0.00
Stoke Therapeutics (STOK) US $0.526B 0.00
Opthea (OPT) AU $0.525B 0.00
Mind Medicine (MindMed) (MNMD) US $0.522B 0.00
REGENXBIO (RGNX) US $0.521B 0.00
Cullinan Therapeutics (CGEM) US $0.519B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) US $0.502B 0.00
Zenas BioPharma (ZBIO) US $0.499B 0.00
Cytek Biosciences (CTKB) US $0.493B 0.00
Maze Therapeutics (MAZE) US $0.475B 0.00
Eton Pharmaceuticals (ETON) US $0.465B 0.00
Upstream Bio (UPB) US $0.464B 0.00
Precigen (PGEN) US $0.463B 0.00
Prothena (PRTA) IE $0.458B 0.00
Sage Therapeutics (SAGE) US $0.457B 0.00
Abivax SA (ABVX) FR $0.456B 0.00
Erasca (ERAS) US $0.448B 0.00
Northwest Biotherapeutics (NWBO) US $0.432B 0.00
Sana Biotechnology (SANA) US $0.426B 0.00
Mereo BioPharma Group - (MREO) GB $0.425B 0.00
PureTech Health (PRTC) US $0.422B 0.00
Oxford BioMedica (OXBDF) GB $0.416B 0.00
Rapport Therapeutics (RAPP) US $0.414B 0.00
Celcuity (CELC) US $0.412B 0.00
Ginkgo Bioworks Holdings (DNA) US $0.409B 0.00
Tectonic Therapeutic (TECX) US $0.406B 0.00
Oric Pharmaceuticals (ORIC) US $0.403B 0.00
MBX Biosciences (MBX) US $0.401B 0.00
Absci (ABSI) US $0.386B 0.00
Olema Pharmaceuticals (OLMA) US $0.384B 0.00
Kamada (KMDA) IL $0.383B 25.61
Verastem (VSTM) US $0.383B 0.00
Allogene Therapeutics (ALLO) US $0.372B 0.00
Autolus Therapeutics (AUTL) GB $0.359B 0.00
Benitec Biopharma (BNTC) US $0.353B 0.00
Entrada Therapeutics (TRDA) US $0.350B 4.83
Alpha Teknova (TKNO) US $0.348B 0.00
Arcturus Therapeutics Holdings (ARCT) US $0.348B 0.00
Checkpoint Therapeutics (CKPT) US $0.345B 0.00
Solid Biosciences (SLDB) US $0.334B 0.00
Septerna (SEPN) US $0.333B 0.00
Cartesian Therapeutics (RNAC) US $0.329B 0.00
Abeona Therapeutics (ABEO) US $0.320B 0.00
ATyr Pharma (ATYR) US $0.320B 0.00
Aura Biosciences (AURA) US $0.309B 0.00
Monte Rosa Therapeutics (GLUE) US $0.306B 0.00
Terns Pharmaceuticals (TERN) US $0.306B 0.00
Fulcrum Therapeutics (FULC) US $0.303B 0.00
Astria Therapeutics (ATXS) US $0.302B 0.00
MaxCyte (MXCT) US $0.300B 0.00
ITeos Therapeutics (ITOS) US $0.297B 0.00
XOMA Royalty (XOMA) US $0.291B 0.00
Emergent Biosolutions (EBS) US $0.279B 0.00
Aardvark Therapeutics (AARD) US $0.279B 0.00
Monopar Therapeutics (MNPR) US $0.275B 0.00
Cidara Therapeutics (CDTX) US $0.272B 0.00
Palvella Therapeutics (PVLA) US $0.270B 0.00
Lifecore Biomedical (LFCR) US $0.270B 0.00
Vanda Pharmaceuticals (VNDA) US $0.269B 0.00
Gossamer Bio (GOSS) US $0.268B 0.00
2seventy Bio (TSVT) US $0.266B 0.00
Design Therapeutics (DSGN) US $0.264B 0.00
Compass Therapeutics (CMPX) US $0.261B 0.00
Candel Therapeutics (CADL) US $0.260B 0.00
ACELYRIN, INC (SLRN) US $0.259B 0.00
Atea Pharmaceuticals (AVIR) US $0.255B 0.00
Kodiak Sciences (KOD) US $0.253B 0.00
Prima BioMed (IMMP) AU $0.250B 0.00
Corvus Pharmaceuticals (CRVS) US $0.247B 0.00
Lexicon Pharmaceuticals (LXRX) US $0.246B 0.00
DBV Technologies S.A (DBVT) FR $0.245B 0.00
Rezolute (RZLT) US $0.242B 0.00
Neurogene (NGNE) US $0.242B 0.00
Foghorn Therapeutics (FHTX) US $0.236B 0.00
BioStem Technologies (BSEM) $0.234B 9.35
Third Harmonic Bio (THRD) US $0.233B 0.00
Bright Minds Biosciences (DRUG) US $0.227B 0.00
Amarin (AMRN) IE $0.226B 0.00
Ocugen (OCGN) US $0.223B 0.00
Prime Medicine (PRME) US $0.220B 0.00
Nuvectis Pharma (NVCT) US $0.218B 0.00
Alumis (ALMS) US $0.217B 0.00
Annexon (ANNX) US $0.216B 0.00
GENFIT S.A (GNFT) FR $0.214B 0.00
Adocia (ADOCY) FR $0.213B 0.00
Anika Therapeutics (ANIK) US $0.213B 0.00
ProQR Therapeutics (PRQR) NL $0.209B 0.00
Codexis (CDXS) US $0.209B 0.00
Actuate Therapeutics (ACTU) US $0.206B 0.00
Humacyte (HUMA) US $0.203B 0.00
Voyager Therapeutics (VYGR) US $0.201B 0.00
Y-mAbs Therapeutics (YMAB) US $0.200B 0.00
CARGO Therapeutics (CRGX) US $0.199B 0.00
Eledon Pharmaceuticals (ELDN) US $0.198B 0.00
EnGene Holdings (ENGN) CA $0.195B 0.00
Phathom Pharmaceuticals (PHAT) US $0.193B 0.00
Innate Pharma S.A (IPHA) FR $0.189B 0.00
Cardiff Oncology (CRDF) US $0.188B 0.00
Semper Paratus Acquisition (TVGN) US $0.186B 0.00
DiaMedica Therapeutics (DMAC) US $0.181B 0.00
INmune Bio (INMB) US $0.178B 0.00
Inventiva S.A (IVA) FR $0.177B 0.00
Inhibrx Biosciences (INBX) US $0.176B 0.00
Adherex Technologies (FENC) US $0.174B 0.00
AC Immune (ACIU) CH $0.173B 0.00
TuHURA Biosciences (HURA) US $0.171B 0.00
Sangamo Therapeutics (SGMO) US $0.167B 0.00
Molecular Partners AG (MOLN) CH $0.165B 0.00
Galena Biopharma (SLS) US $0.165B 0.00
Tango Therapeutics (TNGX) US $0.163B 0.00
Puma Biotechnology (PBYI) US $0.159B 5.26
BioAge Labs (BIOA) US $0.150B 0.00
Fate Therapeutics (FATE) US $0.150B 0.00
Tiziana Life Sciences (TLSA) GB $0.150B 0.00
Nkarta (NKTX) US $0.148B 0.00
Eupraxia Pharmaceuticals (EPRX) CA $0.144B 0.00
ADC Therapeutics SA (ADCT) CH $0.143B 0.00
Editas Medicine (EDIT) US $0.137B 0.00
Vigil Neuroscience (VIGL) US $0.135B 0.00
Greenwich LifeSciences (GLSI) US $0.133B 0.00
Compugen (CGEN) IL $0.132B 0.00
ScPharmaceuticals (SCPH) US $0.131B 0.00
Alector (ALEC) US $0.130B 0.00
Cuprina Holdings (Cayman) (CUPR) SG $0.128B 0.00
Rapt Therapeutics (RAPT) US $0.128B 0.00
Coherus BioSciences (CHRS) US $0.128B 0.00
Theratechnologies (THTX) CA $0.127B 0.00
Neumora Therapeutics (NMRA) US $0.126B 0.00
C4 Therapeutics (CCCC) US $0.124B 0.00
Seer (SEER) US $0.123B 0.00
Sagimet Biosciences (SGMT) US $0.117B 0.00
InflaRx (IFRX) DE $0.116B 0.00
Immunic (IMUX) US $0.110B 0.00
BioHarvest Sciences (BHST) CA $0.107B 0.00
Entera Bio (ENTX) IL $0.107B 0.00
Coya Therapeutics (COYA) US $0.107B 0.00
Contineum Therapeutics (CTNM) US $0.106B 0.00
Orchestra BioMed Holdings (OBIO) US $0.105B 0.00
Inozyme Pharma (INZY) US $0.105B 0.00
Zentalis Pharmaceuticals (ZNTL) US $0.104B 0.00
Pliant Therapeutics (PLRX) US $0.104B 0.00
Ventyx Biosciences (VTYX) US $0.103B 0.00
Alpha Cognition (ACOG) CA $0.102B 0.00
Black Diamond Therapeutics (BDTX) US $0.101B 0.00
Zura Bio (ZURA) US $0.101B 0.00
Genelux (GNLX) US $0.099B 0.00
Kyverna Therapeutics (KYTX) US $0.099B 0.00
HilleVax (HLVX) US $0.098B 0.00
Instil Bio (TIL) US $0.095B 0.00
Sutro Biopharma (STRO) US $0.093B 0.00
EXoZymes (EXOZ) US $0.091B 0.00
TScan Therapeutics (TCRX) US $0.091B 0.00
ANIXA BIOSCIENCES INC (ANIX) US $0.090B 0.00
CervoMed (CRVO) US $0.089B 0.00
XBiotech (XBIT) US $0.089B 0.00
Cellectis S.A (CLLS) FR $0.088B 0.00
Elicio Therapeutics (ELTX) US $0.088B 0.00
Senti Biosciences (SNTI) US $0.087B 0.00
Climb Bio (CLYM) US $0.086B 0.00
Nautilus Biotechnology (NAUT) US $0.085B 0.00
Seres Therapeutics (MCRB) US $0.084B 0.00
Elutia (ELUT) US $0.083B 0.00
Vor Biopharma (VOR) $0.083B 0.00
Biomea Fusion (BMEA) US $0.082B 0.00
Caribou Biosciences (CRBU) US $0.082B 0.00
Jasper Therapeutics (JSPR) US $0.081B 0.00
IGM Biosciences (IGMS) US $0.081B 0.00
I-Mab (IMAB) US $0.077B 0.00
Invivyd (IVVD) US $0.075B 0.00
MediciNova (MNOV) US $0.074B 0.00
Adaptimmune Therapeutics (ADAP) GB $0.074B 0.00
Adverum Biotechnologies (ADVM) US $0.073B 0.00
Genenta Science S.p.A (GNTA) IT $0.073B 0.00
Adagene (ADAG) CN $0.072B 0.00
VTv Therapeutics (VTVT) US $0.072B 0.00
Adlai Nortye (ANL) KY $0.071B 0.00
Inovio Pharmaceuticals (INO) US $0.070B 0.00
Milestone Pharmaceuticals (MIST) CA $0.070B 0.00
Skye Bioscience (SKYE) US $0.069B 0.00
VistaGen Therapeutics (VTGN) US $0.069B 0.00
BeyondSpring (BYSI) US $0.068B 0.00
Cabaletta Bio (CABA) US $0.068B 0.00
Exicure (XCUR) US $0.068B 0.00
Clearside Biomedical (CLSD) US $0.067B 0.00
IO Biotech (IOBT) DK $0.067B 0.00
Citius Oncology (CTOR) US $0.066B 0.00
Alto Neuroscience (ANRO) US $0.066B 0.00
Agenus (AGEN) US $0.066B 0.00
Acumen Pharmaceuticals (ABOS) US $0.065B 0.00
Applied Therapeutics (APLT) US $0.065B 0.00
Prenetics Global (PRE) HK $0.065B 0.00
CytomX Therapeutics (CTMX) US $0.065B 2.11
PDS Biotechnology (PDSB) US $0.063B 0.00
Rani Therapeutics Holdings (RANI) US $0.062B 0.00
Repare Therapeutics (RPTX) CA $0.061B 0.00
Akoya Biosciences (AKYA) US $0.061B 0.00
Achilles Therapeutics (ACHL) GB $0.061B 0.00
Precision BioSciences (DTIL) US $0.061B 0.00
Ikena Oncology (IKNA) US $0.060B 0.00
Artiva Biotherapeutics (ARTV) US $0.059B 0.00
Medicus Pharma (MDCX) US $0.059B 0.00
Immix Biopharma (IMMX) US $0.058B 0.00
Adicet Bio (ACET) US $0.055B 0.00
Fortress Biotech (FBIO) US $0.054B 0.00
Renovaro (RENB) US $0.053B 0.00
ZIVO Bioscience (ZIVO) US $0.053B 0.00
Cyclacel Pharmaceuticals (CYCC) US $0.052B 0.00
PepGen (PEPG) US $0.052B 0.00
Biodexa Pharmaceuticals (BDRX) GB $0.051B 0.00
Oncobiologics (OTLK) US $0.050B 0.00
Mersana Therapeutics (MRSN) US $0.050B 0.00
Shattuck Labs (STTK) US $0.048B 0.00
Oncolytics Biotech (ONCY) CA $0.048B 0.00
Anebulo Pharmaceuticals (ANEB) US $0.047B 0.00
Quince Therapeutics (QNCX) US $0.047B 0.00
Atara Biotherapeutics (ATRA) US $0.047B 0.00
Cue Biopharma (CUE) US $0.047B 0.00
OKYO Pharma (OKYO) $0.046B 0.00
Forte Biosciences (FBRX) US $0.046B 0.00
Connect Biopharma Holdings (CNTB) US $0.046B 0.00
Tenaya Therapeutics (TNYA) US $0.046B 0.00
Immuneering (IMRX) US $0.045B 0.00
Opus Genetics (IRD) US $0.043B 0.00
Kronos Bio (KRON) US $0.043B 0.00
Whitehawk Therapeutics (WHWK) US $0.043B 0.00
Advanced Biomed (ADVB) US $0.042B 0.00
Estrella Immunopharma (ESLA) US $0.042B 0.00
Tvardi Therapeutics (TVRD) US $0.041B 0.00
Werewolf Therapeutics (HOWL) US $0.041B 0.00
TELA Bio (TELA) US $0.040B 0.00
Rein Therapeutics (RNTX) US $0.040B 0.00
CAMP4 Therapeutics (CAMP) US $0.039B 0.00
Xilio Therapeutics (XLO) US $0.039B 0.00
Bluebird Bio (BLUE) US $0.039B 0.00
FibroBiologics (FBLG) US $0.039B 0.00
Lantern Pharma (LTRN) US $0.038B 0.00
Celularity (CELU) US $0.038B 0.00
Scilex Holding (SCLX) US $0.038B 0.00
Barinthus Biotherapeutics (BRNS) GB $0.037B 0.00
AN2 Therapeutics (ANTX) US $0.037B 0.00
Akari Therapeutics (AKTX) GB $0.037B 0.00
RenovoRx (RNXT) US $0.037B 0.00
Spero Therapeutics (SPRO) US $0.036B 0.00
Dyadic (DYAI) US $0.036B 0.00
Boundless Bio (BOLD) US $0.036B 0.00
Pluri (PLUR) IL $0.034B 0.00
Aligos Therapeutics (ALGS) US $0.034B 0.00
LAVA Therapeutics (LVTX) NL $0.034B 0.00
OnKure Therapeutics (OKUR) US $0.034B 0.00
Kezar Life Sciences (KZR) US $0.033B 0.00
BioAtla (BCAB) US $0.033B 0.00
Cadrenal Therapeutics (CVKD) US $0.032B 0.00
Femasys (FEMY) US $0.032B 0.00
Radiopharm Theranostics - (RADX) AU $0.031B 0.00
Grace Therapeutics (GRCE) CA $0.031B 0.00
Alterity Therapeutics - (ATHE) AU $0.031B 0.00
MiNK Therapeutics (INKT) US $0.030B 0.00
Allakos (ALLK) US $0.029B 0.00
Kalaris Therapeutics (KLRS) US $0.029B 0.00
Generation Bio (GBIO) US $0.029B 0.00
ALX Oncology Holdings (ALXO) US $0.028B 0.00
Cognition Therapeutics (CGTX) US $0.028B 0.00
Coeptis Therapeutics Holdings (COEP) US $0.027B 0.00
Clene (CLNN) US $0.027B 0.00
Dare Bioscience (DARE) US $0.026B 0.00
CollPlant Biotechnologies (CLGN) IL $0.025B 0.00
Passage Bio (PASG) US $0.025B 0.00
CalciMedica (CALC) US $0.024B 0.00
KALA BIO (KALA) US $0.024B 0.00
Tenax Therapeutics (TENX) US $0.024B 0.00
Longeveron (LGVN) US $0.023B 0.00
Ovid Therapeutics (OVID) US $0.023B 0.00
Annovis Bio (ANVS) US $0.023B 0.00
Cardio Diagnostics Holdings (CDIO) US $0.022B 0.00
X4 Pharmaceuticals (XFOR) US $0.022B 0.00
Quantum Biopharma (QNTM) CA $0.021B 0.00
Promis Neurosciences (PMN) CA $0.021B 0.00
Lexaria Bioscience (LEXX) CA $0.021B 0.00
Lisata Therapeutics (LSTA) US $0.021B 0.00
Elevation Oncology (ELEV) US $0.021B 0.00
Curis (CRIS) US $0.020B 0.00
Chemomab Therapeutics (CMMB) IL $0.020B 0.00
Q32 Bio (QTTB) US $0.020B 0.00
MIRA Pharmaceuticals (MIRA) US $0.020B 0.00
UNITY Biotechnology (UBX) US $0.019B 0.00
Allarity Therapeutics (ALLR) US $0.019B 0.00
ABVC BioPharma (ABVC) US $0.018B 0.00
Beyond Air (XAIR) US $0.018B 0.00
Gelteq (GELS) AU $0.017B 0.00
Leap Therapeutics (LPTX) US $0.017B 0.00
Cingulate (CING) US $0.017B 0.00
Edesa Biotech (EDSA) CA $0.017B 0.00
Aspire Biopharma Holdings (ASBP) US $0.017B 0.00
HOOKIPA Pharma (HOOK) US $0.016B 0.00
Affimed (AFMD) DE $0.015B 0.00
GeoVax Labs (GOVX) US $0.015B 0.00
Equillium (EQ) US $0.015B 0.00
SAB Biotherapeutics (SABS) US $0.015B 0.00
BRIACELL THERAP (BCTX) CA $0.015B 0.00
Moleculin Biotech (MBRX) US $0.014B 0.00
NeuroSense Therapeutics (NRSN) IL $0.014B 0.00
Synlogic (SYBX) US $0.014B 0.00
Biorestorative Therapies (BRTX) US $0.014B 0.00
IN8bio (INAB) US $0.014B 0.00
BioCardia (BCDA) US $0.014B 0.00
Bolt Biotherapeutics (BOLT) US $0.014B 0.00
Rallybio (RLYB) US $0.013B 0.00
Bionano Genomics (BNGO) US $0.013B 0.00
NextCure (NXTC) US $0.012B 0.00
Imunon (IMNN) US $0.012B 0.00
Abpro Holdings (ABP) US $0.012B 0.00
Hoth Therapeutics (HOTH) US $0.012B 0.00
COSCIENS Biopharma (CSCI) CA $0.012B 0.00
Athira Pharma (ATHA) US $0.011B 0.00
IMMURON (IMRN) AU $0.011B 0.00
LakeShore Biopharma (LSB) CN $0.011B 0.00
Portage Biotech (PRTG) $0.011B 0.00
Sensei Biotherapeutics (SNSE) US $0.011B 0.00
Aerovate Therapeutics (JBIO) US $0.010B 0.00
Aprea Therapeutics (APRE) US $0.010B 0.00
Cyclerion Therapeutics (CYCN) US $0.010B 0.00
IBio (IBIO) US $0.010B 0.00
BioXcel Therapeutics (BTAI) US $0.010B 0.00
Dogwood Therapeutics (DWTX) US $0.010B 0.00
Acurx Pharmaceuticals (ACXP) US $0.009B 0.00
Neuphoria Therapeutics (NEUP) AU $0.009B 0.00
Creative Medical Technology Holdings (CELZ) US $0.009B 0.00
Intensity Therapeutics (INTS) US $0.009B 0.00
Silexion Therapeutics Corp (SLXN) IL $0.009B 0.00
HCW Biologics (HCWB) US $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) US $0.008B 0.00
BioAffinity Technologies (BIAF) US $0.008B 0.00
Turnstone Biologics (TSBX) US $0.008B 0.00
Aytu BioPharma (AYTU) US $0.008B 0.00
GENPREX (GNPX) US $0.007B 0.00
Apollomics (APLM) US $0.007B 0.00
Biofrontera (BFRI) US $0.007B 0.00
MetaVia (MTVA) US $0.007B 0.00
Mainz Biomed (MYNZ) DE $0.007B 0.00
Lipella Pharmaceuticals (LIPO) US $0.006B 0.00
Avalon GloboCare (ALBT) US $0.006B 0.00
Evogene (EVGN) IL $0.006B 0.00
180 Life Sciences (ATNF) US $0.006B 0.00
GT Biopharma (GTBP) US $0.006B 0.00
Dermata Therapeutics (DRMA) US $0.005B 0.00
Soligenix (SNGX) US $0.005B 0.00
Arcadia Biosciences (RKDA) US $0.005B 0.00
Onconetix (ONCO) US $0.005B 0.00
Alzamend Neuro (ALZN) US $0.004B 0.00
Adial Pharmaceuticals (ADIL) US $0.004B 0.00
Polyrizon (PLRZ) IL $0.004B 0.00
Ensysce Biosciences (ENSC) US $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) US $0.004B 0.00
Pasithea Therapeutics (KTTA) US $0.004B 0.00
Galecto (GLTO) DK $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) US $0.004B 0.00
Novogen (KZIA) AU $0.004B 0.00
VivoSim Labs (VIVS) US $0.004B 0.00
Sunshine Biopharma (SBFM) US $0.004B 0.00
Windtree Therapeutics (WINT) US $0.004B 0.00
Mustang Bio (MBIO) US $0.004B 0.00
Palisade Bio (PALI) US $0.003B 0.00
Titan Pharmaceuticals (TTNP) US $0.003B 0.00
Tharimmune (THAR) US $0.003B 0.00
Silo Pharma (SILO) US $0.003B 0.00
Synaptogenix (SNPX) US $0.003B 0.00
Artelo Biosciences (ARTL) US $0.003B 0.00
CNS Pharmaceuticals (CNSP) US $0.003B 0.00
Eyenovia (EYEN) US $0.003B 0.00
Virax Biolabs Group (VRAX) GB $0.003B 0.00
Enveric Biosciences (ENVB) US $0.003B 0.00
Hepion Pharmaceuticals (HEPA) US $0.003B 0.00
Purple Biotech (PPBT) IL $0.003B 0.00
Aptevo Therapeutics (APVO) US $0.003B 0.00
NuCana (NCNA) GB $0.003B 0.00
Scinai Immunotherapeutics (SCNI) IL $0.003B 0.00
Revelation Biosciences (REVB) US $0.003B 0.00
AquaBounty Technologies (AQB) US $0.003B 0.00
Bone Biologics (BBLG) US $0.002B 0.00
Evaxion Biotech (EVAX) DK $0.002B 0.00
Psyence Biomedical (PBM) CA $0.002B 0.00
Atrinsic (PTIX) US $0.002B 0.00
Entero Therapeutics (ENTO) US $0.002B 0.00
ZyVersa Therapeutics (ZVSA) US $0.002B 0.00
NAYA Biosciences (IVF) US $0.001B 0.00
GRI Bio (GRI) US $0.001B 0.00
Capstone Therapeutics (CAPS) US $0.000B 0.00
TFF Pharmaceuticals (TFFP) US $0.000B 0.00
Aceragen (ACGN) US $0.000B 0.00
ARAVIVE, INC (ARAV) US $0.000B 0.00
Clovis Oncology (CLVSQ) US $0.000B 0.00
Cocrystal Pharma (COCP) US $0.000B 0.00
Celyad SA (CYAD) BE $0.000B 0.00
CytoMed Therapeutics (GDTC) SG $0.000B 0.00
Galapagos (GLPG) BE $0.000B 0.00
Motif Bio Plc (MTFB) GB $0.000B 0.00
PDL BioPharma (PDLI) US $0.000B 0.00
Pulmatrix (PULM) US $0.000B 0.00
VectivBio Holding AG (VECT) CH $0.000B 0.00